For the most part, data presented in this study are consistent with previous observations showing over-expression and amplification of MYC in breast cancers [23,59,60], with a notable correlation between MYBL1 and MYC amplification alterations in the TCGA 1015 patient sample TNBC dataset. This evidence concerns the gene MYC and breast cancer.